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esponsibility of InstAbstract Two new phenylpropanoid glycosides named cuneataside E (1) and cuneataside F (2), were
isolated from the aerial parts of Lespedeza cuneata (Dum. Cours.) G. Don, whose structures were E and Z
isomer, respectively. Their structures were elucidated on the basis of comprehensive spectroscopic
analysis (UV, IR, HR-ESI-MS, 1D and 2D NMR). In in vitro bioassays at 10 μmol/L, compound 1
showed moderate hepatoprotective activity against N-acetyl-p-aminophenol (APAP)-induced toxicity in
HeG2 cells.
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Two new phenylpropanoid glycosides from Lespedeza cuneata 5651. Introduction
Lespedeza cuneata (Dum. Cours.) G. Don, an annual herbaceous plant,
is distributed in China, Korea, India, Australia and USA1, which named
“ye guan men” in Chinese, is a very important traditional medicine, and
has been used in the treatment of diabetes2, hematuria, insomnia and
malnutrition3. Previous phytochemical studies have revealed ﬂavonoids,
sterols, triterpenoids4–6 and phenylpropanoid glycosides7 as chemical
constituents of the plant, which showed antioxidant effects8–12, anti-
inﬂammatory effects13 and antibacterial avtivities14. Among them,
ﬂavonoids were the main components of L. cuneata. In our continuing
effort in studying constituents from this important medicinal plant, two
new phenylpropanoid glycosides (Fig. 1) were isolated. Their structures
were elucidated by various spectroscopic methods (UV, IR, HR-ESI-
MS, 1D and 2D NMR). The isolation and structural elucidation of the
new compounds were described in this paper.Figure 2 Key HMBC (arrows, from 1H NMR to 13C NMR)
correlations of compounds 1 and 2.
Figure 1 Structures of compounds 1 and 2.
Figure 3 The NOE enhancements induced by irrad2. Results and discussion
Compound 1 was obtained as a white amorphous powder. The UV
spectrum showed absorption maximums at 210, 228 and 314 nm. In
the IR spectrum, absorption bands at 3375, 2901, 1604, 1515, and
1449 cm1 were observed. These data indicated the presence of
hydroxyl, benzene, and carbonyl groups in 1. The molecular formula
was determined to be C22H30O13 on the basis of HR-ESI-MS m/z
525.1588 [MþNa]þ (Calcd. for C22H30O13Na 525.1579). In the
1H NMR spectrum of 1, a set of AB-type signals at δH7.56 (2H, d,
J¼8.4 Hz, H-2″, 6″) and δH 6.57 (2H, d, J¼8.4 Hz, H-3″, 5″) were
observed, which suggested the existence of a 1,4-disubstituted benzene
ring. Additionally, a methoxy signal at δH 3.35 (3H, s, OMe) and two
anomeric proton signals at δH 4.25 (1H, d, J¼8.0 Hz), δH 4.16 (1H, d,
J¼8.0 Hz) with large coupling constants suggested β-glucosidic
linkages. From the hydrolysate of 1, a neutral residue containing
sugars was obtained by extraction and evaporation. The sugar residue
and authentic D-glucose were separately allowed to react with
L-cycteine methyl ester and N-trimethylsilylimidazole (Section 4.4).
Subsequent GC analysis indicated that two sugar derivatives from the
sugar residue had retention time (tR) identical to that of authentic
D-glucose. This veriﬁed that both glycosyl units in 1 possessed the
D-conﬁguration. We can also ﬁnd trans-disubstituted double bond at δH
7.55 (1H, d, J¼16.0 Hz) and δH 6.43 (1H, d, J¼16.0 Hz), which
suggests that the compound is E isomer. The 13C NMR spectrum
showed 22 carbon signals. An α,β-unsaturated carbonyl group was
demonstrated at δC 166.5. These spectroscopic data indicates that 1 has
a trans-p-coumaroyl and two β-glucopyranosyl groups, for which the
structure was further elucidated by 2D NMR data analysis.
The proton-bearing carbon signals in the NMR spectra were
assigned by cross-peaks in the HSQC spectra. HMBC correlations
from H-1 to C-3, C-5, C–OCH3; from H-6 to C-5, C-4, and C-9″
(Fig. 2); together with their chemical shifts, revealed the presence of a
methoxy group at C-1 and a trans-p-coumaroyl group at C-6. In the
NOE spectra (Fig. 3), an enhancement of the proton signal at the
H-OCH3/H-5 on irradiation of the H-1, and at the H-5 on irradiation of
the H-6 revealed that H-OCH3 and the coumaroyl groups are linked on
the same glucopyranosyl moiety. The HMBC correlations from H-10 to
C-4 demonstrated that two β-glucopyranosyl groups were connected
through a 1,4-linkage. Therefore, the structure of 1 was elucidated as
methyl-6-O-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]-4-O-β-D-glucopyr-
anoside-β-D-glucopyranoside, and named cuneataside E.
Compound 2 was obtained as a white powder, whose molecular
formula was determined to be C22H30O13 on the basis of HR-ESI-MS.
The UV spectrum showed absorption maximums at 210, 227 andiation of H-1 and H-6 for compounds 1 and 2.
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group, carbonyl groups and a benzene ring. In the 1H NMR spectrum
of 2, a set of AB-type signals, one methoxy signal and two aromatic
proton signals were also observed. The 13C NMR spectrum showed
22 carbon signals (12 aromatic carbon signals, 12 saccharide moiety
carbons, one methoxy signals and an α,β-unsaturated carbonyl group).
These NMR spectroscopic data suggested compound 2 shares the
same skeleton as compound 1. The only difference between 1 and 2 is
that 2 has a cis-disubstituted double bond with two oleﬁnic protons
showing at δH 6.86 (1H, d, J¼13.2 Hz) and δH 5.80 (1H, d,
J¼13.2 Hz), which suggest that the compound is Z isomer. The
structure was further elucidated by HSQC, HMBC and NOE data
analysis (Figs. 2 and 3). Thus, the structure of 2 was concluded to be
methyl-6-O-[(Z)-3-(4-hydroxyphenyl)prop-2-enoyl]-4-O-β-D-glucopyr-
anoside-β-D-glucopyranoside, and named cuneataside F.
Compounds 1 and 2 were tested for hepatoprotective activity in the
N-acetyl-p-aminophenol (APAP)-induced toxicity model in HepG2
(human hepatocellular liver carcinoma cell line) cells, using the
hepatoprotective drug bicyclol as the positive control15. As shown in
Table 2, compound 1 exhibited moderate hepatoprotective activity.
3. Conclusions
The plant L. cuneate (Ye guan men) is a known traditional Chinese
medicine. Previous phytochemical studies have shown that ligan
glycosides7 are considered as the characteristic constituents for the
plant L. cuneata. As a part of the ongoing research program for the
discovery of hepatoprotective compounds from L. cuneata, two
new phenylpropanoid glucosides (1 and 2) were isolated from the
aerial parts of this plant. The ﬁndings could provide some insight
into the chemotaxonomic diversity of natural products in the genus
Lespedeza. In an in vitro assay, compound 1 showed moderate
hepatoprotective activity.4. Experimental
4.1. General experimental procedures
Optical rotations were measured on a JASCO P2000 automatic digital
polarimeter. UV spectra were recorded on a JASCO V-650 spectro-
photometer. IR spectra were recorded on a Nicolet 5700 spectrometer
using an FT-IR microscope transmission method. NMR spectra were
acquired with Bruker AVIIIHD 600, VNS-600, or Mercury-400
spectrometers in DMSO-d6. HRESIMS spectra were collected on an
Agilent 1100 series LC/MSD ion trap mass spectrometer. MPLC
system was composed of two C-605 pumps (Büchi), a C-635 UV
detector (Büchi), a C-660 fraction collector (Büchi), and an ODS
column (450 mm 60 mm, 50 μm, 400 g; YMC). Semi-preparative
HPLC was conducted using a Shimadzu LC-6AD instrument with an
SPD-20A detector and a Daicel Chiralpak AD-H column
(250 mm 10 mm, 5 μm). Preparative HPLC was also performed
on a Shimadzu LC-6AD instrument with a YMC-Pack ODS-A column
(250 mm 20 mm, 5 μm). Column chromatography (CC) was per-
formed with silica gel (200–300 mesh, Qingdao Haiyang Chemical
Inc., Qingdao, China), SF-PRP 512 A (100–200 mesh, Beijing Sun-
ﬂower and Technology Development Co., Beijing, China), ODS
(50 μm, YMC, Japan), and Sephadex LH-20 (GE, Sweden). TLC
was carried out on glass precoated silica gel GF254 plates. Spots were
visualized under UV light or by spraying with 10% sulfuric acid in
EtOH followed by heating. GC analyses were obtained using an
Agilent Technologies 7890A instrument.4.2. Plant material
L. cuneata was collected in October 2013 in Xinyang City, Henan
Province, China. The plant material was identiﬁed by Professor
Ceming Tan (JiuJiang Forest Institute). A voucher specimen is
deposited at the Herbarium of the Institute of Material Medical,
Chinese Academy of Medical Sciences and Peking Union Medical
College, China (No. 22276).
4.3. Extraction and isolation
L. cuneata (21 kg) were extracted with 70% EtOH under reﬂux for
three times. After the solvent was evaporated under reduced pressure,
the residue (3.68 kg) was subjected to a diatomite column, eluting with
ether, CHCl3, EtOAc, CH3COCH3, 95% EtOH and 70% EtOH, to
afford six corresponding fractions (Frs. 1–6). Fr. 4 (148 g) was
subjected to CC over polyamide resin eluted with H2O and
EtOH–H2O (30%, 60%, and 95%, v/v) to produce four major fractions
(A, B, C and D). Fr. A (77.2 g) was then divided into four subfractions
(A1–A4) via D101 macroporous adsorption resin CC eluted with H2O
and EtOH–H2O (30%, 60%, and 95%, v/v). Fr. A3 (6.7 g) was
fractionated by sephadex LH-20 CC eluted with MeOH to furnish six
fractions (A3-1–A3-6). Fraction A3-3 (2.1 g) was further separated by
MPLC with MeOH–H2O (20–50%, v/v, 6 h) to yield nineteen fractions
(A3-3-1–A3-3-19). Separation of Fr. A3-3-5 (71 mg) was puriﬁed by
semi-preparative HPLC (3.0 mL/min, 25% MeOH–H2O (v/v) isocratic
elution, detected at 210 nm, tR¼31.6 and 36.4 min) to yield A3-3-5-1
(15 mg) and A3-3-5-2 (47 mg), respectively. A3-3-5-2 was puriﬁed by
semi-preparative HPLC (3.0 mL/min, 13% MeCN-H2O isocratic
elution, detected at 210 nm, tR¼26.8 and 33.6 min) to yield com-
pounds 1 (31 mg) and 2 (7 mg), respectively.
Cuneataside E (1) White amorphous powder, [α]D
20 22.6
(c 0.15, MeOH); UV (MeOH) λmax (logε): 210 (4.26), 228 (4.27),
314(4.59) nm; IR (KBr) νmax: 3375, 2901, 1701, 1632, 1604,
1515, 1449, 1328, 1279, 1170, 1026 cm1; For 1H and 13C NMR
data, see Table 1. HR-ESI-MS m/z 525.1588 [MþNa]þ (Calcd. for
C22H30O13Na, 525.1579).
Cuneataside F (2) White amorphous powder, [α]D
20 20.2 (c
0.11, MeOH); UV (MeOH) λmax (logε): 210 (4.34), 227 (4.32),
313 (4.63) nm; IR (KBr) νmax: 3394, 2921, 1699, 1645, 1604,
1514, 1449, 1419, 1277, 1168, 1050 cm1; For 1H and 13C NMR
data, see Table 1. HR-ESI-MS m/z 525.1589 [MþNa]þ (Calcd. for
C22H30O13Na, 525.1579).
4.4. Determination of absolute conﬁgurations of the sugar
moieties in 1 and 2
Compounds 1 and 2 (2.0 mg) were separately dissolved in 2 mol/L
HCl–H2O (2 mL) and heated at 70 1C for 12 h. After extraction with
EtOAc (3 2 mL) to remove the aglycone, the aqueous layer was
evaporated to afford a neutral residue. The dried sugar residue was
diluted in anhydrous pyridine (1 mL), to which L-cysteine methyl ester
hydrochloride (2 mg) was added. The mixture was stirred at 60 1C for
2 h, and then treated with N-trimethylsilylimidazole (0.2 mL). The
mixture was then heated to dryness at 60 1C for another 2 h. The dried
reactant was partitioned between n-hexane (2 mL) and H2O (2 mL)
three times. The n-hexane layer was concentrated (1 mL) and
subjected to GC analysis (column: HP-5, 60 m 0.25 mm 0.25 μm,
Dikma; detector: FID; detector temperature: 280 1C; injector tempera-
ture: 250 1C; carrier: N2; temperature-programmed: from 200 to
280 1C in 2 min and maintain the ﬁnal temperature 30 min).
Table 1 1H NMR and 13C NMR spectral data (δ) of
compounds in DMSO-d6 (δ in ppm, J in Hz).
No. 1a 2b
δH δC δH δC
1 4.16 d (8.0) 103.3 4.15 d (7.8) 103.4
2 3.09 m 72.9 3.04 m 72.9
3 3.37 m 74.8 3.36 m 74.7
4 3.39 m 80.6 3.34 m 80.7
5 3.62 m 71.8 3.59 m 71.7
6 4.50 dd (12.0, 2.0) 63.0 4.48 d (11.4) 62.9
4.34 dd (12.0, 5.6) 4.34 dd (11.4, 5.4)
10 4.25 d (8.0) 103.4 4.22 d (7.8) 103.4
20 3.00 m 73.2 2.99 m 73.2
30 3.20 m 76.9 3.19 m 76.8
40 3.03 m 70.0 3.04 m 70.0
50 3.13 m 76.5 3.13 m 76.4
60 3.69 m 61.1 3.69 m 61.0
3.41 m 3.39 m
1″ 125.1 125.3
2″, 6″ 7.56 d (8.4) 130.4 7.66 d (8.4) 132.5
3″, 5″ 6.57 d (8.4) 115.8 6.76 d (8.4) 115.2
4″ 159.9 158.8
7″ 7.55 d (16.0) 144.8 6.86 d (13.2) 143.2
8″ 6.43 d (16.0) 114.1 5.80 d (13.2) 114.9
9″ 166.5 165.8
OCH3 3.35 s 56.0 3.33 s 55.9
aData was measured at 400 MHz for 1H NMR and at 100 MHz
for 13C NMR.
bData was measured at 600 MHz for 1H NMR and at 150 MHz
for 13C NMR.
Table 2 Hepatoprotective effects of compounds 1 and 2
(1 105 mol/L) against N-acetyl-p-aminophenol (APAP)-
induced toxicity in HepG2 cells.
Compd. OD
(Mean7SD)
Cell survival rate
(percentage of
normal)
Control 2.22870.067 100.00
APAP (8 mmol/L) 1.25770.024* 56.42
1 1.36670.049## 61.31
2 1.31470.030# 58.96
Bicyclol 1.34370.045## 60.27
#Po0.05, ##Po0.01, compared with APAP-induced model.
*Po0.001, compared with control.
Two new phenylpropanoid glycosides from Lespedeza cuneata 5674.5. Cell viability assay
HepG2 cells were cultured in DMEM medium supplemented with
10% fetal calf serum, 100 U/mL penicillin, and 100 μg/mL strepto-
mycin at 37 1C in a humidiﬁed atmosphere of 5% CO2 and 95% air.
The cells were then passaged by treatment with 0.25% trypsin in
0.02% EDTA. The MTT assay was used to assess the cytotoxicity
of test samples. The cells were seeded in 96-well multiplates. After
an overnight incubation at 37 1C with 5% CO2, 10 μmol/L testsamples and APAP (ﬁnal concentration of 8 mmol/L) were added
into the wells and incubated for another 48 h. Then 100 μL of
0.5 mg/mL MTT was added to each well after the withdrawal of the
culture medium and incubated for an additional 4 h. The resulting
formazan was dissolved in 150 μL of DMSO after aspiration of the
culture medium. The plates were placed on a plate shaker for 30 min
and read immediately at 570 nm using a microplate reader.
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